By Anora Mahmudova, MarketWatch
NEW YORK (MarketWatch) -- The U.S. stock market edged cautiously higher as investors assessed disappointing quarterly results from Campbell Soup Co. and deal news including AstraZeneca's rejection of a $120 billion bid by Pfizer Inc.
In the absence of economic news, investors will pay attention to two Fed speakers later on Monday. Dallas Fed President Richard Fisher, a voting member of the Fed policy committee, and San Francisco Fed President John Williams, a nonvoting member, will speak at a panel in Dallas hosted by former President George W. Bush and his institute at 12:10 p.m. Eastern time.
The S&P 500 index (SPX) was up 2 points, or 0.1%, at 1,879.99. The Dow Jones Industrial Average (DJI) was trading 22 points, or 0.1%, lower at 16,469.13. The Nasdaq Composite (RIXF) added 12 points, or 0.3%, to 4,101.90.
Follow MarketWatch's live blog of today's stock-market action.
In corporate news, Campbell Soup (CPB) shares stumbled 3.7% as weak soup sales led to the company cutting its full-year forecast.
Shares of AT&T (T) fell 1.9% after the telecom giant agreed to buy satellite-television provider DirecTV (DTV) in a stock-and-cash deal worth $67.1 billion, including debt. DirecTV shares also fell 2%.
Google Inc.'s (GOOG) YouTube unit has reached a deal to buy Twitch, a privately held video-streaming service for gamers, for more than $1 billion, according to a report Sunday in Variety, which cited "sources familiar with the pact." Shares in Google were unchanged.
U.S.-listed shares of AstraZeneca (AZN) dropped 10% after the drug maker again rebuffed Pfizer's "final" offer of GBP55 a share ($89.96) saying it undervalues the company. The offer values AstraZeneca at about $120 billion, while the previous offer of GBP50-a-share put the deal at about $106 billion. Pfizer (PFE) shares were up 1.7%.
Apparel and accessories retailer Urban Outfitters (URBN) is scheduled to report first-quarter earnings results late Monday. The company projected to report earnings of 27 cents a share, according to a consensus survey by FactSet.
Asian market fall, gold recaptures the $1,300 level
Asian shares fell, with Shanghai stocks hit following a report that China's property prices are showing further signs of a slowdown amid government curbs. In Europe, the Stoxx Europe 600 was weighed in part by a nearly 13% slide in AstraZeneca shares traded in London.
Among commodities, gold futures rose $8.7 to (GCM4) recapture the $1,300-an-ounce level as stocks weakened. Crude oil (CLM4) rose 79 cents to $102.37 a barrel, and the ICE dollar index (DXY) fell to 79.925 from 80.08 late Friday.
More news from MarketWatch:
Only a 'black swan' will bring back stock volatility
Stocks are telling you a bear market is coming
Stock market's biggest risk is scared consumers
-Anora Mahmudova; 415-439-6400; AskNewswires@dowjones.com
Subscribe to WSJ: http://online.wsj.com?mod=djnwires
(END) Dow Jones Newswires
05-19-14 1010ETCopyright (c) 2014 Dow Jones & Company, Inc.
|U.S. stocks edge higher; S&P 500, Dow at record (2014/5/13)|
|U.S. stocks edge higher; Best Buy, Dollar Tree rally (2014/5/22)|
|UPDATE: U.S. stocks edge higher; S&P nears record level (2014/5/23)|
|U.S. stocks edge higher; S&P nears record level (2014/5/23)|
|U.S. stocks edge higher; Nasdaq lags behind (2014/5/7)|
|UPDATE: U.S. stocks edge higher; Russell 2000 rallies (2014/5/22)|
|UPDATE: U.S. stocks edge higher; Yelp rallies (2014/5/1)|
|Twitter falls, but Facebook, H-P edge higher|
|EBay, Salesforce fall, but techs edge higher|
|UPDATE: U.S. stocks edge lower; S&P 500 retreats from record (2014/5/14)|
|Start Premium Trial||Register For Free|
|P||F||Fund Financial Data (13,000+ funds)|
|P||F||Stock Financial Data (7,000+ stocks)|
|P||F||Stock and Fund Screeners (basic)|
|P||F||Investing Articles and Market Commentary|
|P||F||Articles Archive (>30 days)|
|P||F||Discuss (dozens of stock, fund, bond, and general bulletin boards)|
|P||F||Portfolio Manager (basic)|
|P||F||Morningstar Investment Classroom|
|P||F||Access Your Portfolio Anytime, Anywhere via Your Mobile Device|
|P||Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)|
|P||Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)|
|P||Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)|
|P||Portfolio Monitor (monthly and on-demand personalized portfolio statements)|
|P||Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)|
|P||Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters|
|P||Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)|
|P||Discounts on Morningstar newsletters, books, seminars, and more|
Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.
Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.